Saturday - September 05, 2026

Cost Segregation Studies Deliver Bigger Returns as 100% Bonus Depreciation Becomes Permanent, K-38 Consulting Explains

K-38 Consulting explains that the permanent restoration of 100% bonus depreciation under the One Big Beautiful Bill Act has significantly increased the value of cost segregation studies. Commercial and investment property owners can accelerate depreciation deductions, improve near-term cash flow, … Continue reading

Traverse Hospitality Becomes Largest and Highest-Rated Independent Property Manager at the Crested Butte Base Area, Outpacing the Market as Summer Demand Softens

The Grand Lodge Crested Butte at the base of Crested Butte Mountain Resort, where Traverse Hospitality manages 65 of the building’s 223 condominiums. Photo: Traverse Hospitality. Locally owned manager now operates 101 condos across the Grand Lodge, Lodge at Mountaineer … Continue reading

Liver Cirrhosis Pipeline Gains Momentum: 30+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Gurugram, India (September 02, 2026): DelveInsight’s “Liver Cirrhosis Pipeline Insight 2026” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Liver Cirrhosis Pipeline landscape. It covers the Liver Cirrhosis pipeline drug profiles, including clinical and nonclinical … Continue reading

Parkinson’s Disease Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Gurugram, India (September 02, 2026) –  DelveInsight’s “Parkinson’s Disease Pipeline Insight 2026” report provides comprehensive insights about 150+ companies and 200+ pipeline drugs in Parkinson’s Disease pipeline landscape. It covers the Parkinson’s Disease pipeline drug profiles, including clinical and nonclinical … Continue reading

Atopic Dermatitis Pipeline Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Gurugram, Haryana, India – (September 02, 2026) –  DelveInsight’s “Atopic Dermatitis Pipeline Insight 2026” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the Atopic Dermatitis Pipeline drug profiles, including … Continue reading